Evidence map›Paper›PMID 28724559›Full record

ArticleJournal of clinical microbiology2017

Identification of Leishmania by Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) Mass Spectrometry Using a Free Web-Based Application and a Dedicated Mass-Spectral Library.

Laurence Lachaud, Anna Fernández-Arévalo, Anne-Cécile Normand, Patrick Lami, Cécile Nabet, Jean Luc Donnadieu, Martine Piarroux, Farid Djenad, Carole Cassagne, Christophe Ravel and 10 more

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. An Overview on Leishmaniasis in Romania: Diagnosis and Therapeutics.Tropical medicine and infectious disease · 2022
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Laurence LachaudDépartement de Parasitologie-Mycologie, Centre National de Référence des Leishmanioses, Université de Montpellier, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
Anna Fernández-ArévaloServei de Microbiologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Anne-Cécile NormandLaboratoire de Parasitologie-Mycologie, CHU Timone, Université d'Aix-Marseille, Marseille, France.
Patrick LamiDépartement de Parasitologie-Mycologie, Centre National de Référence des Leishmanioses, Université de Montpellier, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
Cécile NabetLaboratoire Hospitalo-Universitaire de Parasito-Mycologie, EA 3593, EPaT Ecosystèmes Amazoniens et Pathologie Tropicale, Université de Guyane, Laboratoire Associé au CNR Leishmania, Cayenne, France.
Jean Luc DonnadieuAssociation Passerelles, Montpellier, France.
Martine PiarrouxUniversité Aix-Marseille, INSERM-IRD-AMU UMR 912, Marseille, France.
Farid DjenadLaboratoire de Parasitologie-Mycologie, CHU Timone, Université d'Aix-Marseille, Marseille, France.
Carole CassagneLaboratoire de Parasitologie-Mycologie, CHU Timone, Université d'Aix-Marseille, Marseille, France.
Christophe RavelDépartement de Parasitologie-Mycologie, Centre National de Référence des Leishmanioses, Université de Montpellier, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
Silvia TebarSecció de Parasitologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Barcelona, Spain.
Teresa LlovetServei de Microbiologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Denis BlanchetLaboratoire Hospitalo-Universitaire de Parasito-Mycologie, EA 3593, EPaT Ecosystèmes Amazoniens et Pathologie Tropicale, Université de Guyane, Laboratoire Associé au CNR Leishmania, Cayenne, France.
Magalie DemarLaboratoire Hospitalo-Universitaire de Parasito-Mycologie, EA 3593, EPaT Ecosystèmes Amazoniens et Pathologie Tropicale, Université de Guyane, Laboratoire Associé au CNR Leishmania, Cayenne, France.
Zoubir HarratLaboratoire d'Eco-Épidemiologie Parasitaire et Génétique des Populations, Institut Pasteur d'Algerie, Algiers, Algeria.
Karim AounLaboratoire de Parasitologie Médicale, Biotechnologies et Biomolécules, Institut Pasteur de Tunis, Tunis, Tunisia.
Patrick BastienDépartement de Parasitologie-Mycologie, Centre National de Référence des Leishmanioses, Université de Montpellier, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
Carmen MuñozServei de Microbiologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Montserrat GállegoSecció de Parasitologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Barcelona, Spain.
Renaud PiarrouxLaboratoire de Parasitologie-Mycologie, CHU Timone, Université d'Aix-Marseille, Marseille, France mpiarroux@yahoo.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human leishmaniases are widespread diseases with different clinical forms caused by about 20 species within the

Indexed as

Databases, FactualGene LibraryHumansInternetLeishmaniaLeishmaniasisSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionizationdatabaseidentification onlineLeishmaniaMALDI-TOF

Identifiers

PMID28724559
PMCPMC5625378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.